choose between Byetta (exenatide) and Victoza (liraglutide) for type 2 diabetes

Canadians will now be able to choose between Byetta (exenatide) and Victoza (liraglutide) for type 2 diabetes.

Byetta is the new competitor to Victoza. They're both GLP-1 receptor agonists and given by SC injection.

GLP-1 (glucagon-like peptide-1) is an incretin hormone that's secreted by the gut...mainly after meals. GLP-1 stimulates the pancreas to INCREASE insulin and DECREASE glucagon secretion.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote